Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Cerny

Showing results (121-130 of 144) with videos related to

Pageof 15
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 1998
The cognitive-spiritual dimension--an important addition to the assessment of quality of life: validation of a questionnaire (SELT-M) in patients with advanced cancerB van Wegberg, M Bacchi, P Heusser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 1998
Ventricular arrhythmia and torsade de pointe: dose limiting toxicities of the MDR-modulator S9788 in a phase I trialR Stupp, J Bauer, O Pagani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1995
Early versus late alternating chemotherapy in small-cell lung cancer. Swiss Group for Clinical Cancer Research (SAKK)R A Joss, M Bacchi, C Hürny, et al.
British Journal of Cancer|June 28, 2012
Elevated preoperative CEA is associated with worse survival in stage I-III rectal cancer patientsI Tarantino, R Warschkow, M Worni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 26, 1999
Saturable metabolism of continuous high-dose ifosfamide with mesna and GM-CSF: a pharmacokinetic study in advanced sarcoma patients. Swiss Group for Clinical Cancer Research (SAKK)T Cerny, S Leyvraz, T von Briel, et al.
Cancer Chemotherapy and Pharmacology|October 30, 2013
Safety and pharmacology of gemcitabine and capecitabine in patients with advanced pancreatico-biliary cancer and hepatic dysfunctionM Joerger, A D R Huitema, D Koeberle, et al.
Clinical Lymphoma|November 15, 2001
Weekly x 4 induction therapy with the anti-CD20 antibody rituximab: effect on circulating t(14;18)(+) follicular lymphoma cellsG Pichert, S F Schmitz, U Hess, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|April 16, 2014
Discrete improvement in racial disparity in survival among patients with stage IV colorectal cancer: a 21-year population-based analysisA W Castleberry, U Güller, I Tarantino, et al.
British Journal of Cancer|October 13, 2006
Treatment of advanced soft-tissue sarcomas using a combined strategy of high-dose ifosfamide, high-dose doxorubicin and salvage therapiesS Leyvraz, R Herrmann, L Guillou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2000
The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK)M Ghielmini, S F Schmitz, K Bürki, et al.
Pageof 15

Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 1998
The cognitive-spiritual dimension--an important addition to the assessment of quality of life: validation of a questionnaire (SELT-M) in patients with advanced cancerB van Wegberg, M Bacchi, P Heusser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 1998
Ventricular arrhythmia and torsade de pointe: dose limiting toxicities of the MDR-modulator S9788 in a phase I trialR Stupp, J Bauer, O Pagani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1995
Early versus late alternating chemotherapy in small-cell lung cancer. Swiss Group for Clinical Cancer Research (SAKK)R A Joss, M Bacchi, C Hürny, et al.
British Journal of Cancer|June 28, 2012
Elevated preoperative CEA is associated with worse survival in stage I-III rectal cancer patientsI Tarantino, R Warschkow, M Worni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 26, 1999
Saturable metabolism of continuous high-dose ifosfamide with mesna and GM-CSF: a pharmacokinetic study in advanced sarcoma patients. Swiss Group for Clinical Cancer Research (SAKK)T Cerny, S Leyvraz, T von Briel, et al.
Cancer Chemotherapy and Pharmacology|October 30, 2013
Safety and pharmacology of gemcitabine and capecitabine in patients with advanced pancreatico-biliary cancer and hepatic dysfunctionM Joerger, A D R Huitema, D Koeberle, et al.
Clinical Lymphoma|November 15, 2001
Weekly x 4 induction therapy with the anti-CD20 antibody rituximab: effect on circulating t(14;18)(+) follicular lymphoma cellsG Pichert, S F Schmitz, U Hess, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|April 16, 2014
Discrete improvement in racial disparity in survival among patients with stage IV colorectal cancer: a 21-year population-based analysisA W Castleberry, U Güller, I Tarantino, et al.
British Journal of Cancer|October 13, 2006
Treatment of advanced soft-tissue sarcomas using a combined strategy of high-dose ifosfamide, high-dose doxorubicin and salvage therapiesS Leyvraz, R Herrmann, L Guillou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2000
The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK)M Ghielmini, S F Schmitz, K Bürki, et al.
Pageof 15